Needle-Free Injection Systems Market To Surpass $466.2 Million Revenue by 2030, says P&S Intelligence

NEW YORK, June 7, 2022 /PRNewswire/ -- According to the market research report published by P&S Intelligence, in 2021, the needle-free injection systems market size was $151.0 million, which is likely to progress with a 13.3% CAGR from 2021 to 2030, to reach $466.2 million by 2030. The growing diabetic populace, burgeoning occurrence of needle injuries, and dread of needles amongst individuals are the key drivers for the market.

The prefilled bifurcation, within the product segment, is predicted to witness the higher needle-free injection systems market CAGR, in excess of 14%, from 2021 to 2030. Additionally, the U.S. is the major buyer of these devices because of the high count of people with chronic diseases, including diabetes, in the nation. Further, these systems are mostly self-administering, thus help decrease the risk of infection and human dosing errors.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/needle-free-injection-systems-market/report-sample

The higher revenue in the market was generated by reusable devices in the past, as they are cost-effective in the long run, with only the vial requiring regular purchase. The disposable bifurcation is projected to grow at a rapid rate in the years to come. This is because these variants prevent the cross-contamination and injuries associated with needles.

The major share of the revenue in the needle-free injection systems market was held by jet-based category, which is likely to grow with an approximately 14% CAGR. This would be owing to the shorter time consumed in preparing the medication, fewer accidental needlestick pricks, and a reduced risk of infections associated with these variants.

Hospitals and clinics account for the widest usage of these devices. This is credited to the technological improvements, growth in the need for immunization, and surge in the demand for medication delivery systems, because of the high footfall of patients at such centers. The swiftest increase in the usage of these devices is to be seen in home-care settings, because of the speedy increase in diabetic patient volume.

Needle-Free Injection Systems Market Regional Insights

• In 2021, North America was the chief revenue contributor, with an over 40% share, and it is likely to be the market leader till 2030. This is because of the developed infrastructure for healthcare, increase in the patient awareness on safe infections, surge in the occurrence of enduring diseases, and rise in the spending on the development of needle-free injectors by medical device and pharma firms in the region.
• The APAC needle-free injection systems market is likely to have the swiftest growth over this decade. This can be because of an increase in the income and surge in the healthcare expenditure emerging economies. Moreover, emerging economies have a vast unmet need for quality healthcare, which offers wide opportunities to players.

Browse detailed report on Global Needle-Free Injection Systems Market Size, Growth Drivers and Demand Forecast Report 2030

Needleless systems are vastly used for the delivery of insulin. This is credited to the massive diabetic population and the anxiety of needles among people. Diabetes was earlier majorly associated with the elderly, but now, pediatric diabetes is also becoming common. Moreover, since the risk of a needle-related injury does not exist, needle-free injections are a feasible option at homes, hospitals, and clinics.

Needle-Free Injection Systems Market Segmentation Analysis

By Product

• Fillable
• Prefilled

By Type

• Liquid-Based
• Projectile/Depot-Based
• Powder-Based

By Technology

• Jet-Based
• Spring-Based
• Laser-Powered

By Usability

• Disposable
• Reusable

By Delivery Site

• Subcutaneous
• Intramuscular
• Intradermal

By Application

• Vaccine Delivery
• Insulin Delivery
• Pain Management

By End User

• Hospitals & Clinics
• Home-Care Settings
• Research Laboratories

Regional Outlook

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa

Browse Other Reports Published by P&S

Global Aspiration and Biopsy Needles Market Size, Share and Demand Forecast Research Report

Global Hypodermic Needle Market Size, Share and Demand Forecast Research Report

Global Needle-Free Diabetes Management Market Size, Share and Demand Forecast Research Report

Global Prefilled Syringes Market Size, Share and Demand Forecast Research Report

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

SOURCE P&S Intelligence